Thetford Mines, Quebec – TheNewswire - June 30, 2021 – KDA Group Inc. (TSXV:KDA) (“KDA” or the “Corporation”) and its wholly owned subsidiary, Groupe Technologique KDA Inc. (“Tech KDA”) are pleased to announce an important new collaboration with inBay Technologies Inc. (“inBay”), an enterprise-focused cybersecurity company based in Ottawa, Canada. InBay’s industry-leading digital identity solution is expected to help catapult Tech KDA’s technology platforms and services for the pharmaceutical and medical sectors to the forefront with regards to privacy and security.

As Tech KDA moves forward with its international expansion into the United States, Europe, and the United Kingdom, the integration of inBay’s ground-breaking zero-password authentication will serve to strengthen Tech KDA’s position as a market leader by offering the most secure and convenient authentication solution—one that’s truly passwordless—available on the market today.

“In an increasingly digital world where data breaches have become commonplace, KDA is keenly aware of the pressing need for trusted digital identities, where it’s no longer acceptable to have to choose between security and convenience. Moreover, the privacy and security of users’ data is a key priority for KDA and all its subsidiaries, and we firmly believe this collaboration with inBay will enable us to rapidly address this priority,” explained Sylvain Duvernay, Chief Executive Officer of KDA.

“Trusted digital identities are the cornerstone for secure digital transformation, and this is especially crucial in the healthcare sector. inBay was founded on the premise that trust is the real currency in a digital world, and we are proud to continue to help lead the revolution in digital identity with this latest collaboration with KDA and all their subsidiaries,” added Shane Young, President & CEO of inBay.

ABOUT KDA GROUP

KDA Group is a leading technological innovations and specialized solutions provider in the pharmaceutical market. Today, it is a respected name for quality and expertise among the different stakeholders in the pharmaceutical and medical sector. Its management team is guided by a vision of continuing to lead the way in Quebec while extending operations across Canada and internationally. Additional information on the Corporation is available at www.kdagroup.ca and on SEDAR at www.sedar.com.

- 30 -

CAUTION REGARDING FORWARD-LOOKING STATEMENTS

This press release from KDA Group contains forward-looking statements. Forward-looking statements are typically identified by the words assumption, goal, guidance, objective, outlook, strategy, target, and other similar expressions, or future or conditional verbs such as aim, anticipate, believe, predict, could, expect, intend, may, plan, seek, should, strive, and will. By their nature, forward-looking statements require us to make estimates and assumptions and express opinions based on current conditions and anticipated developments, as well as other factors that Management may deem appropriate under the circumstances. There is inherent uncertainty and significant risk in these estimates, assumptions, and opinions, particularly of a commercial, economic, and competitive nature, and they are therefore subject to change. KDA Group cannot guarantee that these estimates, assumptions, and opinions will prove to be accurate.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.

INFORMATION

Sylvain Duvernay

Chief Executive Officer

514 622-7370

info@groupekda.ca